Using Thrombophilia Testing to Determine Anticoagulation Duration in Pediatric Thrombosis is not Cost-Effective

Journal of Pediatrics

Volumn 155, Issue 1, 2009, Pages 100-104

  O'Brien, Sarah H ^a,b   Smith, Kenneth J ^c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTICOAGULANT THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEEP VEIN THROMBOSIS; HEALTH CARE COST; HOSPITALIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; TREATMENT DURATION;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; HUMANS; INFANT; MARKOV CHAINS; MASS SCREENING; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 67649803431     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.01.011     Document Type: Article

References (26)

1. Monagle P., Chalmers E., Chan A.K., deVeber G., Kirkham F., Massicotte P., et al. Antithrombotic Therapy in Neonates and Children: the Eighth ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 133 Suppl (2008) 887S-968S
2. Young G., Albisetti M., Bonduel M., Brandao L., Chan A., Friedrichs F., et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 118 (2008) 1373-1382
3. Auerbach A.D., Sanders G.D., and Hambleton J. Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis. Am J Med 116 (2004) 816-828
4. Eckman M.H., Singh S.K., Erban J.K., and Kao G. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis. Med Decis Making 22 (2002) 108-124
5. Weinstein M.C., Siegel J.E., Gold M.R., Kamlet M.S., and Russell L.B. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276 (1996) 1253-1258
6. Chalmers E.A. Epidemiology of venous thromboembolism in neonates and children. Thromb Res 118 (2006) 3-12
7. Gurgey A., and Aslan D. Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 23 (2001) 159-164
8. Massicotte M.P., Dix D., Monagle P., Adams M., and Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 133 (1998) 770-776
9. Monagle P., Adams M., Mahoney M., Ali K., Barnard D., Bernstein M., et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 47 (2000) 763-766
10. van Ommen C.H., Heijboer H., Buller H.R., Hirasing R.A., Heijmans H.S., and Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 139 (2001) 676-681
11. van Ommen C.H., Heijboer H., van den Dool E.J., Hutten B.A., and Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost 112 (2003) 2516-2522
12. Simioni P., Prandoni P., Lensing A.W., Scudeller A., Sardella C., Prins M.H., et al. The risk of recurrent venous thromboembolism in patients with an Arg506->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 336 (1997) 399-403
13. Gold M.R., Franks P., McCoy K.I., and Fryback D.G. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 36 (1998) 778-792
14. From the Centers for Medicare and Medicaid Services web site. http://www.cms.hhs.gov/PFSlookup Accessed May 9, 2007
15. Drug Topics Red Book (2006), Medical Economics, Montvale, NY
16. From the U.S. Bureau of Labor Statistics web site. http://www.bls.gov/data/ Accessed June 12, 2007
17. Hirth R.A., Chernew M.E., Miller E., Fendrick A.M., and Weissert W.G. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 20 (2000) 332-342
18. Sutor A.H. Screening children with thrombosis for thrombophilic proteins. Cui bono?. J Thromb Haemost 15 (2003) 886-888
19. Manco-Johnson M.J., Grabowski E.F., Hellgreen M., Kemahli A.S., Massicotte M.P., Muntean W., et al. Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost 88 (2002) 155-156
20. Kosch A., Junker R., Kurnik K., Schobess R., Gunther G., Koch H., et al. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res 99 (2000) 531-537
21. Revel-Vilk S., Chan A., Bauman M., and Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 15 (2003) 915-921
22. Griebsch I., Coast J., and Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 115 (2005) e600-e614
23. O'Brien S.H. Decision analysis in pediatric hematology. Pediatr Clin North Am 55 (2008) 287-304 vii
24. Massicotte P., Julian J.A., Gent M., Shields K., Marzinotto V., Szechtman B., et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 109 (2003) 85-92
25. Nowak-Gottl U., Junker R., Kreuz W., von Eckardstein A., Kosch A., Nohe N., et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 97 (2001) 858-862
26. Raffini L.J., Raybagkar D., Blumenstein M.S., Rubenstein R.C., and Manno C.S. Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. J Pediatr 148 (2006) 659-664